Resistant To Chemotherapy

A new study, published in the Journal of Antimicrobial Chemotherapy, indicates another reason that may be increasing the risk of antibiotic resistance.

Scientists have found that immunotherapy can destroy majority of dormant cancer cells that become resistant to chemotherapy and combining the two treatments may help prevent cancer recurrence.

Scientists have identified a second patient in the United States infected with bacteria carrying the mcr-1 "superbug" gene, which makes bacteria highly resistant to a last-resort class of antibiotics.

A new drug can help patients with blood cancers who are resistant to current chemotherapy lead a normal and active life, show results of an international clinical trial, a first-in-man study of the drug.

A new study, published in the Journal of Antimicrobial Chemotherapy, indicates another reason that may be increasing the risk of antibiotic resistance.

Scientists have found that immunotherapy can destroy majority of dormant cancer cells that become resistant to chemotherapy and combining the two treatments may help prevent cancer recurrence.

Scientists have identified a second patient in the United States infected with bacteria carrying the mcr-1 "superbug" gene, which makes bacteria highly resistant to a last-resort class of antibiotics.

A new drug can help patients with blood cancers who are resistant to current chemotherapy lead a normal and active life, show results of an international clinical trial, a first-in-man study of the drug.